Alnylam Pharmaceuticals Inc. (ALNY) Social Stream



Alnylam Pharmaceuticals Inc. (ALNY): $199.55

4.43 (+2.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALNY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 378

in industry

ALNYLAM PHARMACEUTICALS INC (ALNY) Price Targets From Analysts

Use the tables below to see what analysts covering ALNYLAM PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 17 $275 $108 $200 $188.55 6.07%
2021-11-22 18 $275 $108 $200 $188.55 6.07%
2021-12-29 19 $275 $108 $202.5 $188.55 7.4%
2022-01-11 19 $275 $108 $203.85 $188.55 8.11%
2022-01-18 19 $275 $108 $203.3 $188.55 7.82%
2022-01-23 19 $350 $108 $208.3 $188.55 10.47%
2022-01-28 18 $350 $108 $208.2 $188.55 10.42%
2022-02-10 18 $350 $109 $208.65 $188.55 10.66%
2022-02-14 16 $350 $103 $211.684 $188.55 12.27%
2022-02-22 16 $350 $103 $214.166 $188.55 13.59%
2022-03-10 16 $350 $103 $214.631 $188.55 13.83%
2022-04-04 15 $350 $103 $211.277 $188.55 12.05%
2022-04-12 15 $400 $103 $214.055 $188.55 13.53%
2022-04-19 15 $400 $103 $214.277 $188.55 13.64%
2022-04-25 15 $400 $103 $214.277 $188.55 13.64%
2022-04-28 15 $400 $103 $212.5 $188.55 12.7%
2022-05-02 14 $400 $96 $210.944 $188.55 11.88%
2022-06-06 15 $430 $96 $211.888 $188.55 12.38%
2022-06-15 16 $430 $96 $211.888 $188.55 12.38%
2022-06-22 16 $430 $98 $212.333 $188.55 12.61%
2022-07-22 18 $430 $97 $210.157 $188.55 11.46%
2022-07-29 18 $430 $97 $209.631 $188.55 11.18%
2022-08-03 18 $430 $97 $207.842 $188.55 10.23%
2022-08-04 19 $430 $155 $230.055 $188.55 22.01%
2022-08-13 19 $430 $155 $233.117 $188.55 23.64%
2022-08-22 19 $430 $155 $231.5 $188.55 22.78%
2022-09-17 19 $430 $155 $236.5 $188.55 25.43%
2022-10-02 19 $430 $155 $237.888 $188.55 26.17%
2022-10-03 19 $430 $155 $240.058 $188.55 27.32%
2022-10-07 18 $430 $155 $240.058 $188.55 27.32%
2022-10-12 18 $430 $155 $239.941 $188.55 27.26%
2022-10-21 18 $430 $155 $239.882 $188.55 27.22%
2022-10-24 18 $430 $155 $239.647 $188.55 27.1%
2022-10-28 18 $430 $142 $238.352 $188.55 26.41%
2022-10-31 20 $430 $142 $239.684 $188.55 27.12%
2022-11-02 20 $415 $142 $238.894 $188.55 26.7%
2022-12-07 20 $415 $145 $239.052 $188.55 26.78%
2022-12-19 20 $415 $145 $242.105 $188.55 28.4%
2022-12-23 20 $415 $145 $244.263 $188.55 29.55%
2023-01-16 20 $415 $144 $244.21 $188.55 29.52%
2023-01-23 20 $415 $143 $244.157 $188.55 29.49%
2023-01-25 20 $415 $143 $244.684 $188.55 29.77%
2023-01-27 20 $415 $143 $244.736 $188.55 29.8%
2023-02-08 20 $415 $143 $248.888 $188.55 32%
2023-02-21 21 $415 $143 $251.789 $188.55 33.54%
2023-02-24 22 $415 $143 $252.25 $188.55 33.78%
2023-02-26 22 $415 $136 $250.75 $188.55 32.99%
2023-03-03 21 $415 $136 $250.75 $188.55 32.99%

The Trend in the Analyst Price Target


Over the past 14 months, ALNY's average price target has gone up $46.9.

ALNY reports an average of 25.35% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-25 15 400 103 212.500 162.07 31.12%
2022-07-29 18 430 97 209.631 142.04 47.59%
2022-10-31 20 430 142 239.888 207.26 15.74%
2023-01-23 20 415 143 244.157 230.59 5.88%
2023-02-08 20 415 143 248.888 217.75 14.3%

ALNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 13 2 6 0 0 21

The Trend in the Broker Recommendations


Over the past 26 weeks, ALNY's average broker recommendation rating improved by 0.07.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, ALNYLAM PHARMACEUTICALS INC's average analyst price target is greater than 5186.15% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ALNYLAM PHARMACEUTICALS INC's number of analysts covering the stock is greater than 5425.38% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, ALNYLAM PHARMACEUTICALS INC's variance in analysts' estimates is lower than -5125.8% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ALNYLAM PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 813.36% of them.

In the Pharmaceutical Products industry, UTHR, BMRN, and NKTR are the three stocks most similar to ALNYLAM PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for ALNY? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7264 seconds.